Overview
Multiple sclerosis (MS) is a chronic, immune-mediated neuroinflammatory disease of the central nervous system (CNS) characterized by the immune system attacking myelin (the protective sheath surrounding nerve fibers) in the brain, spinal cord, and optic nerves. This autoimmune reaction leads to demyelination, axonal damage, and neurodegeneration, disrupting the speed and integrity of nerve signaling throughout the body.
The immune system, particularly autoreactive T and B cells, improperly crosses the blood–brain barrier and targets components of myelin and oligodendrocytes (the cells that produce myelin). Over time, chronic inflammation leads to irreversible neuronal loss, which contributes to progressive disability.
MS typically follows a relapsing–remitting pattern in early stages, where temporary flare-ups of neurological dysfunction are followed by partial or full recovery. Many patients eventually transition to secondary progressive MS, where disability gradually worsens independent of relapses. A smaller subset presents with primary progressive MS, marked by steady decline from onset.
Common Symptoms
→ Visual disturbances
● optic neuritis, blurred vision, pain with eye movement
→ Sensory changes
● numbness, tingling, neuropathic pain
→ Motor dysfunction:
● weakness, spasticity, gait instability
→ Fatigue
● profound, often disproportionate to activity
→ Coordination and balance difficulties
● cerebellar dysfunction
→ Cognitive changes
● slowed processing, memory impairment, executive dysfunction
→ Autonomic dysfunction
● urinary urgency/retention, bowel issues, sexual dysfunction
→ Dysarthria and dysphagia
→ Heat sensitivity
● (Uhthoff’s phenomenon)
Root Causes & Triggers
01. INFECTIONS
→ EBV
→ Lyme
→ Retroviral
● HERV-W/ MSRV (Found microglia, astrocytes and macrophages in the brains of MS patients as well as the inner lining of the venous system)
- Found microglia, astrocytes and macrophages in the brains of MS patients as well as the inner lining of the venous system
- MSRV contains highly neurotoxic envelope proteins (found in the serum of 73% of MS patients not in controls)
→ Viral
● HHV6 (herpes)
● HHV4 (EBV)
→ Bacterial
● Chylmydia pneuomniae
→ Parasite
● Toxoplama gondii
02. TOXINS
→ Heavy metals
● mercury, cadmium correlated with disease severity
→ Glyphosate
→ Mycotoxins
● Cross or disrupt the BBB, cause myelin loss and oligodendrocyte injury, and produce white‑matter and neurocognitive changes that resemble MS and other demyelinating conditions in animal and cell models.
03. CIRCADIAN
→ Dysregulation of melatonin
→ Altered expression of clock genes
● Shift work and circadian disruption have been associated with increased MS risk
04. TRAUMA
→ Microglial priming and blood–brain barrier permeability invite autoreactive lymphocytes. Flares often track with chronic unpredictability and isolation
→ Motor conflict
→ Paralyzing fear
→ Conflict of not being able, or allowed to move.
● According to Dr. Sabbah: Obedience conflict. One believes that they always have to carry out all commands.
→ The beginning of this conflict may lie in the childhood years:
● One is broken (tamed) during the defiant phase. Saying no is not allowed – authority must be obeyed mercilessly.
Our Approach
Our approach understands that Multiple Sclerosis is the body’s intelligent response to chronic dysregulation across the Four Pillars: circadian disruption, toxic burden, unresolved infections, and unprocessed trauma.
Effective treatment begins by identifying which of these key levers are most disrupted in your biology and unique health story using functional blood analysis, specific immune testing, Bioresoance and Autonomic Response Testing.
Once we uncover your unique levers we work in sequence to systematically bring the body back into a state of healing. We first restore circadian rhythm integrity to recalibrate hormonal, mitochondrial, and immune timing. We then open the drainage pathways to ensure the body can safely eliminate what has been overwhelming it. From there, we reduce toxic burden, systematically address stealth infections in the correct order and resolve the trauma patterns that keep the nervous system locked in defense mode.
Autoimmunity heals when the terrain heals. The goal is not immune suppression, but restoration creating an internal environment where inflammation is no longer required and the immune system can finally return to balance, clarity, and trust.
References
- Attar AM, et al. Serum mercury level and multiple sclerosis. Biol Trace Elem Res. 2012 May;146(2):150-3.
- Armon-Omer A, et al. Association between multiple sclerosis and urinary levels of toxic metals and organophosphates: A cross-sectional study in Israel. Mult Scler Relat Disord. 2024 Mar;83:105445.
- Samsel A, Seneff S. Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases. Journal of Biological Physics and Chemistry. 2017 Mar:8-32
- Purzycki CB, Shain DH. Fungal toxins and multiple sclerosis: a compelling connection. Brain Res Bull. 2010 Apr 29;82(1-2):4-6.
- Skarlis C, Anagnostouli M. The role of melatonin in Multiple Sclerosis. Neurol Sci. 2020 Apr;41(4):769-781.
- Damasceno A, et al. Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study. J Neurol Sci. 2015;353(1-2):166-8.
- Canever, J. B., et al. (2024). Circadian rhythm alterations affecting the pathology of neurodegenerative diseases. Journal of Neurochemistry, 168, 1475–1489.
- Moses H Jr, Sriram S. An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents. BioDrugs. 2001;15(3):199-206.
- Nicoletti A, et al. Toxoplasma gondii and multiple sclerosis: a population-based case-control study. Sci Rep. 2020 Nov 2;10(1):18855.
- Pizzorno J, Shippy A. Is Mold Toxicity Really a Problem for Our Patients? Part 2-Nonrespiratory Conditions. Integr Med (Encinitas). 2016 Jun;15(3):8-14.
- Mojtaba Ehsanifar, Reihane Rajati, Akram Gholami, Joseph P Reiss. Mold and Mycotoxin Exposure and Brain Disorders. J. Integr. Neurosci. 2023, 22(6), 137.
- Doskaliuk B, Zimba O. Borrelia burgdorferi and autoimmune mechanisms: implications for mimicry, misdiagnosis, and mismanagement in Lyme disease and autoimmune disorders. Rheumatol Int. 2024 Nov;44(11):2265-2271.
Contents
The Autoimmune Revival Book
Inside the book, you’ll discover how modern science and embodied healing can work together to create sustainable vitality.
The Autoimmune Revival Free Course
The same breakthrough that saved my wife has now helped hundreds of patients break free from chronic fatigue, pain, and inflammation, naturally and permanently.
The Autoimmune Revival Book
Inside the book, you’ll discover how modern science and embodied healing can work together to create sustainable vitality.
The Autoimmune Revival Free Course
The same breakthrough that saved my wife has now helped hundreds of patients break free from chronic fatigue, pain, and inflammation, naturally and permanently.
